Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. v1 supports \"company\"."New value: +"Entity type: \"company\" or \"drug\"."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "drug"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker, CIK, or company name (e.g., \"AAPL\", \"0000320193\", \"Apple\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."
  3. Added

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already signal read-only, non-destructive, idempotent behavior. The description goes well beyond this by disclosing important behavioral traits: ambiguity handling via figi_candidates, explicit unresolved identifiers, graceful degradation when GLEIF/OpenFIGI are unavailable, and the ISIN-to-legal-entity mapping. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense, with many parentheticals and asides, but nearly every clause adds operational value. It is front-loaded with examples and the core usage rule, and the verbose type-specific sections are justified by the tool's multi-source behavior.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the burden of explaining return contents, and it does: CIK/ticker/company_name, LEI and ownership, FIGI, RxCUI/ingredient/brand, plus failure behaviors like unresolved and figi_candidates. It also covers input edge cases and external-source degradation, making the tool safe and predictable for an agent to invoke.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3, but the description adds substantial meaning beyond the schema: concrete examples (AAPL, CH0038863350, ozempic), the accepted input forms for company, and a critical caveat about passing the entity name only rather than the full noun phrase. This materially improves correct invocation.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states a specific verb and resource: it resolves user-spoken names to canonical/official identifiers that other tools consume. It enumerates supported types (company, drug) and distinguishes itself from siblings by emphasizing it is the first stop when you have a name but need an ID.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit context for when to use it ('Use FIRST whenever you have a name but need an ID') and provides numerous query examples. However, it does not explicitly name alternative sibling tools or state when NOT to use it, so it stops short of full exclusion guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

Several tools have genuinely unclear boundaries: ask_pipeworx and ask_pipeworx_beta are described as currently identical, ask_pipeworx_grounded shares the same router, and the polymarket_edges/arbitrage/fill_risk/bet_research group overlaps heavily in purpose. The remaining clusters (dog data, memory, subscriptions) are mostly distinct, so the confusion is concentrated in a few spots but severe there.

Naming Consistency3/5

Nearly all names are lower_snake_case and readable, but the conventions are mixed: get_/list_/ask_/scan_ verb-noun names sit alongside bare verbs (remember, forget, recall), noun-phrase names (entity_profile, bet_research, pipeworx_trending), and a versioned suffix (ask_pipeworx_beta). No single predictable pattern covers the whole set.

Tool Count2/5

At 35 tools, the server is well past the 25+ threshold for feeling bloated, and the count is dominated by unrelated Pipeworx, prediction-market, and AI-visibility tools rather than the dog-data domain implied by 'dogsapi'. Only four tools actually serve the dog API, making the surface both oversized and misaligned with the server name.

Completeness3/5

The broad data-access side is thorough, covering discovery, universal routing, grounded answers, deep research, entity profiles, comparisons, claim validation, memory, and subscriptions. However, the nominal dog domain is thin (list/get/groups/facts with no filtering or additional operations), subscriptions have no update path, and some one-off tools like generate_llms_txt and scan_dependency exist without any surrounding lifecycle.